On August 14, 2024, Aion Therapeutic Inc., a company based in Toronto, Ontario, announced that it will not be able to file its annual audited consolidated financial statements for the fiscal year ending April 30, 2024, along with other related documents, by the Filing Deadline of August 28, 2024. This delay is due to the acquisition of Toppen Health, Inc. on December 15, 2023, which requires valuation and impairment testing processes to be completed. As a result, the Company has requested a management cease trade order effective August 14, 2024. The Company expects to have the necessary filings completed and submitted by the end of September 2024.
Aion Therapeutic is a company focused on health and wellness, with a range of intellectual property. Its subsidiary, Toppen, specializes in water filtration solutions for consumers, businesses, and industries. This press release contains forward-looking information regarding the company’s business and goals, the timing of financial disclosures, and the management cease trade order. Readers are advised to consider the inherent uncertainties of forward-looking information and the risks involved. The securities of the company have not been registered under the United States Securities Act.
For more information, please visit the original source of this press release: [link to source].
